Tannins as Therapeutic Agents for Ulcerative Colitis: Mechanisms and Prospects in Regulating Gut

Yanling Li1, Can Sun1, Fuqi Hao2

  • 1College of Pharmacy, North Henan Medical University, Xinxiang 453003, China.

Insights

Tannins show promise for ulcerative colitis (UC) by reducing inflammation and oxidative stress. Further research is needed to improve tannin bioavailability for effective UC treatment.

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Ulcerative colitis (UC) involves chronic intestinal inflammation and oxidative imbalance, impacting patient quality of life.
  • Tannins, plant-derived polyphenols, possess antioxidant and anti-inflammatory properties with therapeutic potential for UC.

Purpose of the Study:

  • To systematically review the molecular mechanisms of tannin action in restoring intestinal homeostasis in UC.
  • To explore the potential of tannins as a therapeutic strategy for ulcerative colitis.

Main Methods:

  • Systematic literature review of PubMed and Web of Science databases.
  • Analysis of studies investigating tannin effects on oxidative stress and inflammation in UC models.

Main Results:

  • Tannins scavenge reactive oxygen species (ROS) and mitigate oxidative damage through their polyphenolic structure.
  • Tannins upregulate antioxidant enzymes, suppress pro-inflammatory cytokines, and maintain intestinal barrier integrity.
  • Evidence suggests tannins can restore intestinal inflammatory and oxidative homeostasis.

Conclusions:

  • Tannins exhibit significant therapeutic promise for ulcerative colitis by targeting key inflammatory and oxidative pathways.
  • Challenges including low bioavailability and structural complexity require further investigation for clinical translation.
  • Future research should focus on enhancing bioavailability and clarifying structure-activity relationships for tannin-based UC therapies.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
667
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
989
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
716
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
19.7K